Trond Undheim, PhD, Program Director, MIT Startup Exchange in collaboration with Anne Deconinck, PhD, Executive Director, MIT Koch Institute for Integrative Cancer Research
Jan Schnorr, CEO, C2Sense
Alan Kriz - Open Innovation and Investment
Charles Fracchia, Founder, BioBright
Chazz Sims, Founder, Wise Systems
Katharine Sepp, Co-founder & CEO, Oxalys Pharmaceuticals
Lightning Talks featuring startups: Enbiotix, Ginkgo Bioworks, ManusBio, Glympse Bio, BioDevek, Asimov, and BioBuilder.
"Trends in Wellness Investments", David T. Thibodeau, Managing Director, Wellvest Capital
Scalable production of RNA for agriculture Andrey Zarur, Cofounder & CEO, GreenLight Biosciences Potassium fertilizer innovation Philip Wender, Managing Director, Advanced Potash Technologies Chemiresistive gas sensing for food safety Merry Smith, Senior Scientist, C2Sense Novel dehumidifying material for indoor farms Sorin Grama, Cofounder, Transaera Probiotics for plants Michael Miille, CEO, Joyn Bio [Joyn is a JV between Ginkgo Bioworks and Leaps by Bayer]
Trond Undheim, PhD, Program Director, MIT Startup Exchange; Paula Hammond, PhD, David H. Koch Professor in Engineering and Department Head, Chemical Engineering, MIT; Laura Indolfi, PhD, CEO of PanTher Therapeutics; Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.